Indian J Pharm Close
 

Figure 6: Significant changes in expression of epithelial and mesenchymal markers on oropharyngeal aspiration administration of bleomycin. (a) E-cadherin, (b) α-Smooth muscle actin and (c) vaimentin, and (d) ?bronectin, respectively, and respective densitometric analysis were normalized with β-actin. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 of bleomycin versus control

Figure 6: Significant changes in expression of epithelial and mesenchymal markers on oropharyngeal aspiration administration of bleomycin. (a) E-cadherin, (b) α-Smooth muscle actin and (c) vaimentin, and (d) ?bronectin, respectively, and respective densitometric analysis were normalized with β-actin. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> < 0.0001 of bleomycin versus control